Want to join the conversation?
Joseph Spak of RBC Capital Markets asks if there is any change to the outlook in China for the year 2016. CFO Charles Stevens replied that $GM has not changed its outlook for China. He added that the company continues to expect strong performance in China with equity income in the range of $2Bil, consistent with 2015 and margins in the 9-10% range.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?